Ausgabe 2/2022
Inhalt (20 Artikel)
short review
Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
Georg C. Hutterer, Martin Pichler
Open Access
short review
Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022
Jan-Paul Bohn
Open Access
short review
Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer
Maximilian Marhold
Open Access
short review
Tracking mutation and drug-driven alterations of oncokinase conformations
Andreas Feichtner, Valentina Kugler, Selina Schwaighofer, Thomas Nuener, Jakob Fleischmann, Eduard Stefan
case report
Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report
Ahmed H. Al Sharie, Yazan O. Al Zu’bi, Sarah Al Sharie, Hawra A. Baydoun, Farah H. Atawneh, Osama Alshari, Dima Albals
case report
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report
Maher Salamoon, Mazen Kenj
original report
High mortality in patients with active malignancy and severe COVID-19
Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger, Christoph Aichinger, Kathrin Strasser-Weippl, Holger Rumpold, Andreas Petzer, Ewald Wöll, Wolfgang Hilbe, Ercan Müldür
interview
Cardiopulmonary sequelae of COVID-19
case report
Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature
Simon Udovica, Kathrin Strasser-Weippl, Eva Fischer, Dora Niedersüß-Beke
case report
Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab
Beatrix Mutschlechner, Susanne Dertinger, Felix Offner, Veronika Buck, Alexander Becherer, Klaus Gasser, Bernd Hartmann, Thomas Winder